Skip to main content
News Directory 3
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Video: Influencer Hospitalized After Ozempic - Warning Signs - News Directory 3

Video: Influencer Hospitalized After Ozempic – Warning Signs

January 29, 2026 Ahmed Hassan World
News Context
At a glance
  • The drug semaglutide, initially developed to treat type 2 ⁤diabetes, has gained popularity for ⁢its weight loss⁣ effects, leading to increased recreational use and raising serious health concerns.
  • Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, originally designed to help manage blood sugar levels ⁣in individuals with type 2 ⁤diabetes.
  • It effectively works by mimicking the effects of GLP-1,a natural hormone that slows gastric emptying,increases insulin release,and reduces appetite,ultimately leading to ⁢weight loss.
Original source: eldia.com

“`html



<a href="https://www.newsdirectory3.com/kim-kardashians-secret-to-timeless-beauty-wigobi-diet-pill-unveils-a-surprising-anti-aging-benefit/" title="Kim Kardashian's Secret to Timeless Beauty: 'Wigobi' Diet Pill Unveils a Surprising Anti-Aging Benefit">Semaglutide</a> ⁣Risks and Concerns

Semaglutide Use for Weight Loss:‍ Risks and Expert Warnings

Table of Contents

  • Semaglutide Use for Weight Loss:‍ Risks and Expert Warnings
    • What is Semaglutide?
    • Potential Health Risks of Unsupervised Semaglutide use
    • Expert ⁢Consensus and ⁣Regulatory warnings

The drug semaglutide, initially developed to treat type 2 ⁤diabetes, has gained popularity for ⁢its weight loss⁣ effects, leading to increased recreational use and raising serious health concerns. Experts warn that using semaglutide without medical⁤ supervision can led to severe adverse effects, despite its appeal for effortless weight loss.

What is Semaglutide?

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, originally designed to help manage blood sugar levels ⁣in individuals with type 2 ⁤diabetes. The Food and Drug Administration (FDA) approved semaglutide under ⁤the brand name Wegovy for⁤ chronic weight⁣ management in adults with obesity or overweight with at least one weight-related condition in⁣ June 2021.

It effectively works by mimicking the effects of GLP-1,a natural hormone that slows gastric emptying,increases insulin release,and reduces appetite,ultimately leading to ⁢weight loss. ⁣ The delayed digestion and⁤ increased ⁤satiety are key ⁣mechanisms behind its effectiveness.

Example: A clinical trial published in ⁤the New England Journal of Medicine showed that adults with obesity who⁣ received semaglutide 2.4 mg once ⁣weekly lost an average of 15% of⁣ their initial body⁣ weight over ⁤68 weeks, compared to 2.4% ⁢with⁤ placebo.

Potential Health Risks of Unsupervised Semaglutide use

Using semaglutide without proper⁢ medical supervision carries significant health risks, extending beyond ⁣common side effects like nausea. these risks can be severe and⁣ even life-threatening.

These risks include:

  • Hypoglycemia: ‍ Low blood sugar, particularly dangerous for individuals without diabetes.
  • Gallbladder Problems: semaglutide⁤ can‍ increase the risk of ⁣gallbladder issues, ‍including gallstones. ⁣ The Mayo Clinic ‍details the symptoms and causes of gallstones.
  • Pancreatitis: Inflammation of the pancreas, a serious⁢ and possibly fatal condition.
  • Thyroid Tumors: In animal ⁣studies,semaglutide has been linked to thyroid C-cell tumors. The relevance⁣ to humans is still being investigated. The FDA provides patient information regarding this risk.
  • Severe Allergic Reactions: As with any medication, allergic reactions are possible.

Evidence: The European⁤ Medicines Agency (EMA) has issued ‍warnings about potential risks associated with semaglutide, including ⁢gallbladder problems and pancreatitis, and emphasizes the need for careful patient selection and monitoring.

Expert ⁢Consensus and ⁣Regulatory warnings

Medical professionals overwhelmingly agree that using semaglutide for cosmetic or recreational purposes without medical oversight is dangerous. Health authorities are actively warning against ⁤this practice.

Quote: “semaglutide is not a quick fix for weight loss, and it’s not without risks,” says Dr. ⁤Fatima‍ Cody Stanford, an obesity medicine specialist at Massachusetts General Hospital, in a NBC News report. “It should onyl be used under the guidance of a qualified healthcare provider.”

Regulatory Action: In January 2024, the FDA

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Ozempic

Search:

News Directory 3

News Directory 3 catalogs US newspapers, news services, newsstands and digital news outlets across all 50 states. Browse local publishers by city, state, or topic, and follow current headlines linked back to their original sources.

Quick Links

  • Disclaimer
  • Terms and Conditions
  • About Us
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Editorial Guidelines
  • Privacy Policy

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

© 2026 News Directory 3. All rights reserved.
For contact, advertising, copyright, issues email: office@newsdirectory3.com